WANBURY
|
The Current P/S Ratio of WANBURY is 1.25.
Share Price | ₹219.7 | Jan 28,2025 |
Market Cap | ₹720.5 Cr | |
Sales-TTM | ₹577.2 Cr | TTM-Consolidated Results |
Price/Sales | 1.25x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WANBURY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹720.5 Cr] as on Jan 28,2025
(/) Sales [ ₹577.2 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.25x ]
Thus, for WANBURY , the investors are currently willing to pay '1.25 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WANBURY !
The chart below summarizes the trend in P/S Ratio of WANBURY over the last five years.
Historical PS (Price/Sales) ratio chart of WANBURY
PS Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.45x.
- WANBURY 's operated at median p/e ratio of 0.53x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2024 at 0.83x.
- WANBURY 's p/e ratio hit its five-year low in Mar2020 of 0.12x.
How does WANBURY 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WANBURY | 577.2 | 1.25 | 720.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.14 | 409,303.0 |
CIPLA LTD | 26,981.2 | 4.25 | 114,645.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.15 | 98,449.5 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.26 | 91,587.4 |
DIVIS LABORATORIES LTD | 8,614.0 | 16.65 | 143,389.0 |
MANKIND PHARMA LTD | 11,641.0 | 8.71 | 101,440.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 9.92 | 112,169.0 |
LUPIN LTD | 21,431.3 | 4.31 | 92,321.3 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.18 | 66,080.7 |
ABBOTT INDIA LTD | 6,066.1 | 9.02 | 54,708.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WANBURY 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.25x |
Max industry PS | 16.65x |
Median industry PS | 4.31x |
Average industry PS | 6.53x |
You may also like the below Video Courses